ARROWHEAD PHARMACEUTICALS IN's ticker is ARWR and the CUSIP is 04280A100. A total of 254 filers reported holding ARROWHEAD PHARMACEUTICALS IN in Q3 2023. The put-call ratio across all filers is 0.72 and the average weighting 0.2%.
Quarter-by-quarter ownership
| Value | Shares | Weighting | ||||
|---|---|---|---|---|---|---|
| Q3 2023 | $1,247,279 | -79.1% | 46,419 | -72.2% | 0.01% | -76.7% |
| Q2 2023 | $5,957,181 | +128.2% | 167,055 | +299.6% | 0.03% | +400.0% |
| Q3 2021 | $2,610,000 | +18.7% | 41,803 | +57.4% | 0.01% | +20.0% |
| Q2 2021 | $2,199,000 | +6.0% | 26,554 | -15.1% | 0.01% | 0.0% |
| Q1 2021 | $2,074,000 | -23.5% | 31,273 | -11.5% | 0.01% | -28.6% |
| Q4 2020 | $2,710,000 | +489.1% | 35,321 | +120.8% | 0.01% | +600.0% |
| Q1 2020 | $460,000 | -48.2% | 16,000 | +14.3% | 0.00% | -66.7% |
| Q4 2019 | $888,000 | – | 14,000 | – | 0.00% | – |
Download | ||||||
Other shareholders
| Name | Shares | Value | Weighting ↓ |
|---|---|---|---|
| WESTERN FINANCIAL Corp | 820,346 | $62,945,000 | 41.38% |
| Johnson & Johnson Innovation - JJDC, Inc. | 3,260,869 | $250,206,000 | 32.27% |
| Aquilo Capital Management, LLC | 365,926 | $28,078,000 | 5.84% |
| L1 Capital Pty Ltd | 298,687 | $23,127,000 | 4.32% |
| First Light Asset Management, LLC | 704,449 | $54,052,000 | 4.00% |
| ACUTA CAPITAL PARTNERS, LLC | 139,000 | $10,665,000 | 2.90% |
| Evolutionary Tree Capital Management, LLC | 48,265 | $3,703,000 | 2.82% |
| Parkman Healthcare Partners LLC | 127,171 | $9,758,000 | 2.50% |
| Capital Impact Advisors, LLC | 88,183 | $6,766,000 | 1.66% |
| Tri Locum Partners LP | 56,003 | $4,297,000 | 1.56% |